| Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells PA Sotiropoulou, SA Perez, M Salagianni, CN Baxevanis, M Papamichail Stem cells 24 (2), 462-471, 2006 | 893 | 2006 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 467 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 347 | 2021 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 137 | 2022 |
| CD4+ CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients SA Perez, MV Karamouzis, DV Skarlos, A Ardavanis, NN Sotiriadou, ... Clinical Cancer Research 13 (9), 2714-2721, 2007 | 137 | 2007 |
| Toll-like receptor 7 protects from atherosclerosis by constraining “inflammatory” macrophage activation M Salagianni, IE Galani, AM Lundberg, CH Davos, A Varela, A Gavriil, ... Circulation 126 (8), 952-962, 2012 | 129 | 2012 |
| A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy F Kussebi, F Karamloo, C Rhyner, P Schmid-Grendelmeier, M Salagianni, ... Journal of allergy and clinical immunology 115 (2), 323-329, 2005 | 121 | 2005 |
| Prevention of allergy by a recombinant multi‐allergen vaccine with reduced IgE binding and preserved T cell epitopes F Karamloo, P Schmid‐Grendelmeier, F Kussebi, M Akdis, M Salagianni, ... European journal of immunology 35 (11), 3268-3276, 2005 | 106 | 2005 |
| Cell culture medium composition and translational adult bone marrow‐derived stem cell research PA Sotiropoulou, SA Perez, M Salagianni, CN Baxevanis, M Papamichail Stem Cells 24 (5), 1409-1410, 2006 | 98 | 2006 |
| Interferon-λs: front-line guardians of immunity and homeostasis in the respiratory tract E Andreakos, M Salagianni, IE Galani, O Koltsida Frontiers in immunology 8, 1232, 2017 | 87 | 2017 |
| NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses M Salagianni, E Lekka, A Moustaki, EG Iliopoulou, CN Baxevanis, ... The Journal of Immunology 186 (6), 3327-3335, 2011 | 56 | 2011 |
| Induction of potent CD4+ T cell‐mediated antitumor responses by a helper HER‐2/neu peptide linked to the Ii‐Key moiety of the invariant chain IF Voutsas, AD Gritzapis, LG Mahaira, M Salagianni, E Hofe, ... International journal of cancer 121 (9), 2031-2041, 2007 | 56 | 2007 |
| Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs P Bastard, SE Vazquez, J Liu, MT Laurie, CY Wang, A Gervais, ... Science immunology 8 (90), eabp8966, 2023 | 45 | 2023 |
| An essential role for IL-18 in CD8 T cell-mediated suppression of IgE responses M Salagianni, WK Loon, MJ Thomas, A Noble, DM Kemeny The Journal of Immunology 178 (8), 4771-4778, 2007 | 43 | 2007 |
| New insights into the role of NK cells in cancer immunotherapy M Salagianni, CN Baxevanis, M Papamichail, SA Perez Oncoimmunology 1 (2), 205-207, 2012 | 38 | 2012 |
| CD8+ T cells in beige adipogenesis and energy homeostasis M Moysidou, S Karaliota, E Kodela, M Salagianni, Y Koutmani, ... JCI insight 3 (5), 2018 | 31 | 2018 |
| Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function NN Sotiriadou, SA Perez, AD Gritzapis, LG Mahaira, M Salagianni, ... Cellular immunology 234 (1), 67-75, 2005 | 22 | 2005 |
| Treatment with a Toll‐like Receptor 7 ligand evokes protective immunity against atherosclerosis in hypercholesterolaemic mice G Karadimou, A Gisterå, AL Gallina, AS Caravaca, M Centa, M Salagianni, ... Journal of internal medicine 288 (3), 321-334, 2020 | 14 | 2020 |
| Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis P Makras, M Salagianni, K Revelos, AD Anastasilakis, M Schini, M Tsoli, ... The Journal of Clinical Endocrinology & Metabolism 100 (2), E282-E286, 2015 | 12 | 2015 |
| Autoantibodies are highly prevalent in non–SARS-CoV-2 respiratory infections and critical illness A Feng, EY Yang, AR Moore, S Dhingra, SE Chang, X Yin, R Pi, ... JCI insight 8 (3), 2023 | 11 | 2023 |
